Clay Shearer, MD
Dermatology · Florence, KYNPI 1881601961
Payments from drug & device makers
Across 582 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- Novartis$886
- Lilly USA, LLC$806
- Regeneron Healthcare Solutions, Inc.$676
- UCB, Inc.$657
- plus $2K from 32 others
What the payments were for
- Food & beverage$9,67697%
- Education$2563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 226 | $3,409 |
| Johnson & Johnson(2 entities) | 75 | $1,385 |
| Novartis | 51 | $886 |
| Lilly USA, LLC | 50 | $806 |
| Regeneron Healthcare Solutions, Inc. | 30 | $676 |
| UCB, Inc. | 33 | $657 |
| Sanofi | 19 | $362 |
| Sun Pharmaceutical Industries Inc. | 16 | $292 |
| E.r. Squibb & Sons, L.L.C. | 8 | $154 |
| Incyte Corporation | 8 | $152 |
| Galderma Laboratories, L.p. | 9 | $132 |
| LEO Pharma Inc. | 7 | $123 |
| Kyowa Kirin, Inc. | 6 | $100 |
| Helsinn Therapeutics (U.S.), Inc. | 5 | $98 |
| Genentech USA, Inc. | 4 | $60 |
| Sientra, Inc. | 2 | $54 |
| Amgen | 3 | $54 |
| Strata Skin Sciences, Inc. | 4 | $44 |
| Paratek Pharmaceuticals, Inc. | 3 | $42 |
| VYNE Pharmaceuticals Inc. | 2 | $39 |
| Pfizer | 2 | $36 |
| Medline Industries LP | 1 | $35 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $34 |
| Almirall LLC | 2 | $32 |
| Organogenesis Inc. | 1 | $26 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $24 |
| Krystal Biotech Inc | 1 | $23 |
| Mylan Institutional Inc. | 1 | $19 |
| Convatec Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $18 |
| Dermira, Inc. | 1 | $17 |
| LNHC, Inc | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $16 |
| Icad, Inc | 1 | $15 |
| Merck | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $13 |
How this compares
$9,932 in reported general payments places this provider in the 75th percentile of 128 dermatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $165,234 |
| Cosentyx Unoready PenSecukinumab | 16 | $121,600 |
| Fluticasone Propionate | 328 | $6,674 |
| Metronidazole | 74 | $6,545 |
| Fluocinonide | 89 | $3,709 |
| Minocycline Hcl | 91 | $2,737 |
| Fluorouracil | 28 | $2,225 |
| Tretinoin | 26 | $1,608 |
| Ketoconazole | 113 | $1,283 |
| Triamcinolone Acetonide | 123 | $1,274 |
| Imiquimod | 24 | $816 |
| Clindamycin Phosphate | 32 | $815 |
| Clobetasol Propionate | 31 | $759 |
| Doxycycline Hyclate | 45 | $648 |
| ValacyclovirValacyclovir Hcl | 24 | $622 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Florence
- Kristen AhernFlorence$7K
- David ShearerFlorence$7K
- Clayton ConnerFlorence$6K
- Leon KircikLousiville$10M
- Cindy OwenLouisville$4.2M
- James AllredFranklin$2.7M
- Melissa KnucklesCorbin$1.6M
- Artis TruettOwensboro$1.4M
- James WhartonLexington$1.2M
- Jae JungLouisville$651K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.